Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Dopamine and serotonin have been indirectly found to be associated with generalized anxiety disorder (GAD). The aims of this study were to examine the availabilities of the striatal dopamine transporter (DAT) and the midbrain serotonin transporter (SERT) in patients with GAD. 12 patients with GAD and 12 sex-matched, age-matched, and smoking status-matched healthy controls were recruited. The availabilities of DAT and SERT were approximated using single-photon emission computed tomography, with [Tc]TRODAT-1 and [I]ADAM as the ligands. There were several missing data for six participants with GAD in the ADAM study because of a lack of the radioligand at the time of the experiment. The DAT availability in the striatum was significantly lower in the patients with GAD than in the healthy controls. However, the SERT availability did not differ between the two groups. The results with respect to the striatal DAT level suggested a potential role in the pathophysiology of GAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nikolaus, S., Antke, C., Beu, M., & Müller, H.-W. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.2.119 · Cited by 243 · cited 1×
“The dopaminergic system has been found to be associated with GAD (Nikolaus et al., 2010).”
BackgroundLee, J. K., & Orsillo, S. M. (2014) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2013.10.008 · Cited by 171
Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder
Hesse, S., Müller, U., Lincke, T., Barthel, H., Villmann, T., Angermeyer, M. C., Sabri, O., & Stengler-Wenzke, K. (2005) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2005.07.002 · Cited by 155 · cited 1×
“The above-mentioned results were inconsistent (Hesse et al., 2005; Schneier et al., 2009).”
Cited by
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Comorbidity between ADHD and Anxiety Disorders across the Lifespan
D’Agati, E., Curatolo, P., & Mazzone, L. (2019) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2019.1628277 · Cited by 165
Biological markers of generalized anxiety disorder
Maron, E., & Nutt, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/dnutt · Cited by 164
Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment
Fu, X., Wu, W., Wu, Y., Liu, X., Liang, W., Wu, R., & Li, Y. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1597559 · Cited by 54
Biological Markers of Generalized Anxiety Disorder
Maron, E., & Nutt, D. (2018) · Focus · doi:10.1176/appi.focus.16205 · Cited by 42
Metadata
- Authors
- Lee, L.-T., Tsai, H. C., Chi, M. H., Chang, W. H., Chen, K. C., Lee, I. H., Chen, P. S., Yao, W. J., Chiu, N. T., & Yang, Y. K.
- Venue
- International Clinical Psychopharmacology
- Published
- 2015-05
- Volume
- 30
- Issue
- 3
- Pages
- 175-178
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2034545632
- Cited by
- 35
- References
- 3
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study. https://app.cochat.ai/papers/10.1097/yic.0000000000000067
- The paper
- Lee, L.-T., Tsai, H. C., Chi, M. H., Chang, W. H., Chen, K. C., Lee, I. H., Chen, P. S., Yao, W. J., Chiu, N. T., & Yang, Y. K. (2015). Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000067
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.